Replies to post #10687 on Algernon Pharmaceuticals Inc (AGNPF)

[Money $hot]

My best guess is the SK study will be hanging out there and on the message boards for as long as it takes until we get data from the multinational clinical trial. I remain of the belief IF the SK study has patients we would have heard about first patient dosed. Surely someone will bring up a non disclosure agreement, but I think I recall the CEO stating if/when they got to patient dosing they would announce it. So looking at what you posted here:

One research site was initiated at the end of May, 2020, and two sites were initiated in early June for the investigator-led COVID-19 phase 2 trial in South Korea. Dr. Dong Sik Jung, professor, in the division of infectious disease of Dong-A University Hospital, has now begun the process of screening patients.

I would conclude by saying, IF any patients were dosed, the process is so slow they don't want to report anyone dosed because getting to 20 patients my never happen.

Just 1 opinion.

I'll send no more re-PLIES until Monday.

Chillin @ The Ritz-Carlton.



Peace 3x

/////AMG

[tcm55]

The article is a month old and I'm hopeful...GLTA...